Skip to main content
SpringerLink
Log in

Psychopharmacological Treatment

  • Chapter
Handbook of Child Psychopathology

Abstract

Pharmacotherapy, at the present state of our knowledge, is viewed only as an adjunct to psychosocial and other treatments in certain disturbed children. It has been said that, even in adults, the only lasting effect of a drug is indirect: that is, it is a result of the changed interaction between the patient and his or her environment due to concurrent psychosocial treatment(s) (Irwin, 1968). The nondrug treatments in children include individual psychotherapy, behavior modification, remedial work, and parental counseling. It is expected that a therapeutically effective drug will make the disturbed child more amenable to these treatments, or that it will enhance (interact with) them.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achenbach, T. M. (1978). Psychopathology of childhood: Research problems and issues. Journal of Consulting and Clinical Psychology, 46, 759–776.

    PubMed  Google Scholar 

  • Alexandris, H., and Lundell, F. (1968). Effect of thioridazine, amphetamine, and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children. Canadian Medical Association Journal, 98, 92–96.

    PubMed  Google Scholar 

  • Aman, M. G. (1978). Drugs, learning and the psychotherapies. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Brunner/Mazel.

    Google Scholar 

  • Aman, M. G. (1984). Drugs and learning in mentally retarded persons. In G. D. Burrows and J. S. Werry (Eds.), Advances in human psychopharmacology. Greenwich, CT: JAI.

    Google Scholar 

  • Aman, M. G., and Singh, N. N. (1983). Pharmacological intervention. In J. L. Matson and J. A. Mulick (Eds.), Handbook of mental retardation. New York: Pergamon Press.

    Google Scholar 

  • Aman, M. G., and Werry, J. S. (1975). The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action. Psychopharmacologia (Berlin), 43, 163–168.

    Google Scholar 

  • Aman, M. G., and White, A. J. (1986). Measures of drug change in mental retardation. In K. D. Gadow (Ed.), Advances in learning and behavioral disabilities. Greenwich, CT: JAI.

    Google Scholar 

  • American Psychiatric Association. (1968). Diagnostic and statistical manual of mental disorders ( 2nd ed. ). Washington, DC: Author.

    Google Scholar 

  • American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders ( 3rd ed. ). Washington, DC: Author.

    Google Scholar 

  • American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed. rev.). Washington, DC: Author.

    Google Scholar 

  • Anderson, L. T., Campbell, M., Grega, D. M., Perry, R. Small, A. M., and Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195–1202.

    PubMed  Google Scholar 

  • Anderson, L. T., Campbell, M., Adams, P., Small, A. M., Perry, R., and Shell, J. (1989). The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Developmental Disorders.

    Google Scholar 

  • Annell, A. L. (Ed.). (1972). Depressive states in childhood and adolescence. Stockholm: Almquist and Wiksell.

    Google Scholar 

  • Beghi, E., et al. (1986). Adverse reactions to antiepileptic drugs: A multicenter survey of clinical practice, collabortive group for epidemiology of epilepsy. Epilepsia, 27, 323–330. New York: Raven Press.

    Google Scholar 

  • Berger, P. A., and Rexroth, K. (1980). Tardive dyskinesia: Clinical, biological, and pharmacological perspectives. Schizophrenia Bulletin, 6, 102–116.

    PubMed  Google Scholar 

  • Boileau, R. A., Ballard, J. E., Sprague, R. L., Sleator, E. K., and Massey, B. H. (1976). Effect of methylphenidate on cardiorespiratory responses in hyperactive children. Research Quarterly, 47, 590–596.

    PubMed  Google Scholar 

  • Bradley, C. (1937). The behavior of children receiving Benzedrine. American Journal of Psychiatry, 94, 577–585.

    Google Scholar 

  • Bradley, C. (1950). Benzedrine and dexedrine in the treatment of children’s behavior disorders. Pediatrics, 5, 24–37.

    PubMed  Google Scholar 

  • Bradley, C., and Bowen, M. (1941). Behavior characteristics of schizophrenic children. Psychiatric Quarterly, 15, 298–315.

    Google Scholar 

  • Broughton, R. J. (1969). Sleep disorders: Disorders of arousal? Science, 158, 1070–1078.

    Google Scholar 

  • Bruun, R. D. (1982). Clonidine treatment of Tourette syndrome. Advances in Neurology 35, 404–405.

    Google Scholar 

  • Bruun, R. D. (1984). Gilles de la Tourette’s syndrome. Journal of the American Academy of Child Psychiatry, 23, 126–133.

    PubMed  Google Scholar 

  • Bruun, R. D. ( 1987, May). Tourette’s children: Underrecognized side effects. Paper presented at the symposium, Neuroleptics in Children: Efficacy and Side Effects, 140th Annual Meeting of the American Psychiatric Association.

    Google Scholar 

  • Bruun, R. D., Shapiro, A. K., and Shapiro, E. (1976). A followup of 78 patients with Gilles de la Tourette’s syndrome. American Journal of Psychiatry, 133, 944–947.

    PubMed  Google Scholar 

  • Campbell, M. (1977). Demographic parameters of disturbed children: A template to the CPDI and CSH-Its rationale and significance. Psychopharmacology Bulletin, 13, 30–33.

    PubMed  Google Scholar 

  • Campbell, M. (1978). The use of drug treatment in infantile autism and childhood schizophrenia: A review. In M. A. Lipton, A. DiMascio, and K. Killam (Eds.), Psychopharmacology: A generation of progress. New York: Raven Press.

    Google Scholar 

  • Campbell, M. (1979). Psychopharmacology. In J. D. Noshpitz (Ed.), Basic handbook of child psychiatry (Vol. 3 ). New York: Basic Books.

    Google Scholar 

  • Campbell, M. (1985). On the use of neuroleptics in children and adolescents. Psychiatric Annals, 15, 101–107.

    Google Scholar 

  • Campbell, M. (1987). Drug treatment of infantile autism: The past decade. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress. New York: Raven Press.

    Google Scholar 

  • Campbell, M. (1988). Fenfluramine treatment of autism. Annotation. Journal of Child Psychology and Psychiatry, 29, 110.

    Google Scholar 

  • Campbell, M., and Cohen, I. L. (1981). Psychotropic drugs in childhood psychiatry. In: H. M. van Praag (Ed.), Handbook of Biologic Psychiatry, New York: Marcel Dekker.

    Google Scholar 

  • Campbell, M., and Deutsch, S. I. (1985). Neuroleptics in children. In G. D. Burrows, T. Norman, and B. Davies (Eds.), Drugs in Psychiatry: Vol. 3. Antipsychotics. Amsterdam: Elsevier Biomedical Press.

    Google Scholar 

  • Campbell, M., and Palij, M. (1985a). Behavioral and cognitive measures used in psychopharmacological studies of infantile autism. Psychopharmacology Bulletin, 21, 1047–1053.

    PubMed  Google Scholar 

  • Campbell, M., and Palij, M. (1985b). Documentation of demographic data and family history of psychiatric illness. Psycho-pharmacology Bulletin, 21, 719–733.

    Google Scholar 

  • Campbell, M., and Palij, M. (1985c). Measurement of untoward effects including tardive dyskinesia. Psychopharmacology Bulletin, 21, 1063–1082.

    PubMed  Google Scholar 

  • Campbell, M., Fish, B., Shapiro, T., and Floyd, A., Jr. (1970). Thiothixene in young disturbed children: A pilot study. Archives of General Psychiatry, 23, 70–72.

    PubMed  Google Scholar 

  • Campbell, M., Fish, B., Shapiro, T., andFloyd, A. (1971). Study of molindone in disturbed preschool children. Current Therapeutic Research, 13, 28–33.

    PubMed  Google Scholar 

  • Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., and Koh, C. (1972). Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children. Journal of Autism and Childhood Schizophrenia, 2, 234–263.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C., and Sachar, E. (1978a). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17, 640–655.

    PubMed  Google Scholar 

  • Campbell, M., Schulman, D., and Rapoport, J. L. (1978b). The current status of lithium therapy in child and adolescent psychiatry. Journal of the American Academy of Child Psychiatry, 17, 717–720.

    PubMed  Google Scholar 

  • Campbell, M., Small, A. M., Hollander, C. S., Korein, J., Cohen, I. L., Kalmijn, M., and Ferris, S. A. (1978c). A controlled crossover study of triiodothyronine in young psychotic children. Journal of Autism and Childhood Schizophrenia, 8, 371–381.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L. T., Cohen, I. L., Perry, R., Small, A. M., Green, W. H., Anderson, L., and McCandless, W. H., Jr. (1982a). Haloperidol in autistic children: Effects on learning, behavior, and abnormal involuntary movements. Psycho-pharmacology Bulletin, 18, 110–112.

    Google Scholar 

  • Campbell, M., Cohen, I. L., Small, A. M. (1982b). Drugs in aggressive behavior. Journal of the American Academy of Child Psychiatry, 21, 107–117.

    PubMed  Google Scholar 

  • Campbell, M., Grega, D. M., Green, W. H., and Bennett, W. G. (1983). Neuroleptic-induced dyskinesias in children. Clinical Neuropharmacology, 6, 207–222.

    PubMed  Google Scholar 

  • Campbell, M., Perry, R., and Green, W. H. (1984a). The use of lithium in children and adolescents. Psychosomatics, 25, 95–106.

    PubMed  Google Scholar 

  • Campbell, M., Small, A. M., Green, W. H., Jennings, S. J., Perry, R., Bennett, W. G., and Anderson, L. (1984b). Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 41, 650–656.

    PubMed  Google Scholar 

  • Campbell, M., Green, W. H., and Deutsch, S. I. (1985). Child and Adolescent Psychopharmacology. Beverly Hills, CA: Sage.

    Google Scholar 

  • Campbell, M., Perry, R., Polonsky, B. B., Deutsch, S. I., Palij, M., and Lukashok, D. (1986). Brief report: Fenfluramine in hospitalized young autistic children: An open study. Journal of Autism and Developmental Disroders, 16, 495–506.

    Google Scholar 

  • Campbell, M., Adams, P., Small, A. M., Curren, E. L., Overall, J. E., Anderson, L. T., Lynch, N., Perry, R. (1988a). Efficacy and safety of fenfluramine in autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 434–439.

    PubMed  Google Scholar 

  • Campbell, M., Adams, P., Small, A. M., Tesch, L. M., and Curren, E. L. (1988b). Naltrexone in infantile autism. Psychopharmacology Bulletin, 24, 135–139.

    PubMed  Google Scholar 

  • Campbell, M., Adams, P., Perry, R., Spencer, E. K., and Overall, J. E. (1988c). Tardive and withdrawal dyskinesia in autistic children: A prospective study. Psychopharmacology Bulletin, 24, 251–255.

    PubMed  Google Scholar 

  • Carlson, G. H., and Cantwell, D. P. (1980). Unmasking masked depression in children and adolescents. American Journal of Psychiatry, 137, 445–449.

    PubMed  Google Scholar 

  • Chassan, J. B. (1979). Research design in clinical psychology and psychiatry ( 2nd ed. ). New York: Irvington.

    Google Scholar 

  • Christensen, D. E. (1973). Combined effects of methylphenidate Ritalin and a classroom behavior modification program in reducing the hyperkinetic behaviors of institutionalized mental retardates. Doctoral dissertation, University of Illinois at Urbana-Champaign.

    Google Scholar 

  • Christensen, D. E., and Sprague, R. L. (1973). Reduction of hyperactive behavior by conditioning procedures alone and combined with methylphenidate (Ritalin). Behavior Research and Therapy, 11, 331–334.

    Google Scholar 

  • Cohen, D. J., Shaywitz, B. A., Young, J. G., Carbonari, C. M., Nathanson, J. A., Lieberman, D., Bowers, M. B., and Maas, J. W. (1979a). Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette. Journal of the American Academy of Child Psychiatry, 18, 320–341.

    PubMed  Google Scholar 

  • Cohen, D. J., Young, J. G., Nathanson, J. A., and Shaywitz, B. A. (1979b). Clonidine in Tourette’s syndrome. Lancet, 551–552.

    Google Scholar 

  • Cohen, D. J., Detlor, J., Young, J. G., and Shaywitz, B. A. (1980a). Clonidine ameliorates Gilles de la Tourette syndrome. Archives of General Psychiatry, 37, 1350–1357.

    PubMed  Google Scholar 

  • Cohen, I. L., Campbell, M., Posner, D., Small, A. M., Triebel, D., and Anderson, L. T. (1980b). Behavioral effects of haloperidol in young autistic children: An objective analysis using a within-subjects reversal design. Journal of the American Academy of Child Psychiatry, 19, 665–677.

    PubMed  Google Scholar 

  • Coleman, N., Dexheimer, P., DiMascio, A., Redman, W., and Finnerty, R. (1976). Deanol in the treatment of hyperkinetic children. Psychosomatics, 17, 68–72.

    PubMed  Google Scholar 

  • Comings, D. E., and Comings, B. G. (1984). Tourette’s syndrome and attention deficit with hyperactivity: Are they genetically related? Journal of the American Academy of Child Psychiatry, 23, 138–146.

    PubMed  Google Scholar 

  • Connell, P. H., Corbett, J. A., Horne, D. J., and Mathews, A. M. (1967). Drug treatment of adolescent tiguers: A double-blind trial of diazepam and haloperidol. British Journal of Psychiatry, 113, 375–381.

    PubMed  Google Scholar 

  • Conners, C. K. (1972). Pharmacotherapy of psychopathology in children. In H. C. Quay and J. S. Werry (Eds.), Psychopathological disorders of childhood. New York: Wiley, 1972.

    Google Scholar 

  • Conners, C. K. (1973). Deanol and behavior disorders in children: A critical review of the literature and recommended future studies for determining efficacy. Psychopharmacology Bulletin ( Special Issue: Pharmacotherapy of Children, 188–195 ).

    Google Scholar 

  • Conners, C. K. (1975). Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. In R. Gittelman-Klein (Ed.), Recent advances in child psychopharmacology. International Journal of Mental Health, 4(No. 12 ), 61.

    Google Scholar 

  • Conners, C. K. (1976). Classification and treatment of childhood depression and depressive equivalents. In I). M. Gallant and G. M. Simpson (Eds.), Depression: Behavioral, biochemical, diagnostic and treatment concepts. New York: Spectrum.

    Google Scholar 

  • Conners, C. K. (1980a). Artificial colors in the diet and disruptive behaviors. In R. N. Knights and D. Bakker (Eds.), Treatment of hyperactive and learning disordered children. Baltimore: University Park Press, 1980.

    Google Scholar 

  • Conners, C. K. (1980b). Food additives and hyperactive children. New York: Plenum Press.

    Google Scholar 

  • Conners, C. K., (1985). Issues in the study of adolescent ADD-H/ hyperactivity. Psychopharmacology Bulletin, 21, 243–250.

    PubMed  Google Scholar 

  • Conners, C. K., and Goyette, C. H. (1977). The effect of certified food dyes on behavior: A challenge test. New Clinical Drug Evaluation Unit Intercom, 7, 18–19.

    Google Scholar 

  • Conners, C. K., and Taylor, E. (1980). Pemoline, methylphenidate and placebo in children with minimal brain dysfunction. Archives of General Psychiatry, 37, 922–930.

    PubMed  Google Scholar 

  • Conners, C. K., and Werry, J. S. (1979). Pharmacotherapy. In H. C. Quay and J. S. Werry (Eds.), Psychopathological disorders of childhood ( 2nd ed. ). New York: Wiley.

    Google Scholar 

  • Conners, C. K., Eisenberg, L., and Barcai, A. (1967). Effect of dextroamphetamine on children. Archives of General Psychiatry, 17, 478–484.

    PubMed  Google Scholar 

  • Conners, C. K., Rothschild, G., Eisenberg, L., Schwartz, L. S., and Robinson, E. (1969). Dextroamphetamine sulfate in children with learning disorders. Archives of General Psychiatry, 21, 182–190.

    PubMed  Google Scholar 

  • Conners, C. K., Taylor, E., Meo, G., Kurtz, M. A., and Fournier, M. (1972). Magnesium pemoline and dextroamphetamine: A controlled study in children with minimal brain dysfunction. Psychopharmacologia, 26, 321–336.

    PubMed  Google Scholar 

  • Conners, C. K., Goyette, C. H., Southwick, D. A., Lees, J. H., and Andrulonis, P. A. (1976). Food additives and hyperkinesis: A controlled double-blind experiment. Pediatrics, 58, 154166.

    Google Scholar 

  • Conners, C. K., Glasgow, A., Raiten, D., Caldwell, J., Caldwell, L., and Clymer, R. ( 1987, August). Hyperactives differ from normals in blood sugar and hormonal response to sucrose. Presented at the Annual Meeting of the American Psychological Association, New York.

    Google Scholar 

  • Conrad, W. G., Dworkin, E. S., Shai, A., and Tobiessen, J. E. (1971). Effects of amphetamine therapy and prescriptive tutoring on the behavior and achievement of lower class hyperactive children. Journal of Learning Disabilities, 4, 509–517.

    Google Scholar 

  • Cytryn, L., McKnew, D., and Bunney, W. E. (1980). Diagnosis of depression in children: A reassessment. American Journal of Psychiatry, 137, 22–25.

    PubMed  Google Scholar 

  • Davis, K. V., Sprague, R. L., and Werry, J. S. (1969). Stereotyped behavior and activity level in severe retardates: The effect of drugs. American Journal of Mental Deficiency, 73, 721–727.

    PubMed  Google Scholar 

  • DeLong, G. R., and Aldershof, A. L. (1987). Long-term experience with lithium treatment in childhood correlation with clinical diagnosis. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 389–394.

    PubMed  Google Scholar 

  • Denckla, M. B., Bemporad, J. R., and MacKay, M. C. (1976). Tics following methylphenidate administration. Journal of the American Medical Association, 235, 1349–1351.

    PubMed  Google Scholar 

  • Deutsch, S. I. (1986). Rationale for the administration of opiate antagonists in treating infantile autism. American Journal of Mental Deficiency, 90, 631–635.

    PubMed  Google Scholar 

  • Dische, S. (1971). Management of enuresis. British Medical Journal, 2, 33.

    PubMed  Google Scholar 

  • Doke, L. A. (1976). Assessment of children’s behavioral deficits. In M. Hersen and A. S. Bellack (Eds.), Behavioral assessment: A practical handbook. Oxford: Pergamon Press.

    Google Scholar 

  • Donnelly, M., Rapoport, J. L., and Ismond, D. R. (1986). Fenfluramine treatment of childhood attention deficit disorder with hyperactivity: A preliminary report. Psychopharmacology Bulletin, 22, 152–159.

    PubMed  Google Scholar 

  • Dostal, T. (1972). Antiaggressive effect of lithium salts in mentally retarded adolescents. In A. L. Annell (Ed.), Depressive states in childhood and adolescence. Stockholm: Almqvist and Wiksell.

    Google Scholar 

  • Douglas, V. (1974). Differences between normal and hyperkinetic children. In C. K. Conners (Ed.), Clinical use of stimulant drugs in children. Amsterdam: Excerpta Medica.

    Google Scholar 

  • Dykman, R. A., McGrew, J., Harris, T. S., Peters, J. E., and Ackerman, P. T. (1976). Two blinded studies of the effects of stimulant drug on children: Pemoline, methylphenidate, and placebo. In R. P. Anderson and C. G. Halcomb (Eds.), Learning disability/Minimal brain dysfunction syndrome. Springfield, IL: Charles C. Thomas.

    Google Scholar 

  • Engelhardt, D. M., and Polizos, P. (1978). Adverse effects of pharmacotherapy in childhood psychosis. In M. A. Lipton, A. DiMascio, and K. F. Killam (Eds.), Psychopharmacology: A generation of progress. New York: Raven Press.

    Google Scholar 

  • Engelhardt, D. M., Polizos, P., Waizer, J., and Hoffman, S. P. (1973). A double-blind comparison of fluphenazine and haloperidol. Journal of Autism and Childhood Schizophrenia, 3, 128–137.

    PubMed  Google Scholar 

  • Evans, R. W., Clay, T. H., and Gualtieri, C. T. (1987). Carbamazepine in pediatric psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 2–8.

    PubMed  Google Scholar 

  • Farber, J. M. (1987). Review article, Psychopharmacology of self-injurious behavior in the mentally retarded. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 296–303.

    PubMed  Google Scholar 

  • Feinberg, M., and Carroll, B. J. (1979). Effects of dopamine agonists and antagonists in Tourette’s disease. Archives of General Psychiatry, 36, 979–985.

    PubMed  Google Scholar 

  • Feingold, B. F. (1974). Hyperkinesis and learning difficulties (H-LD) linked to the ingestion of artificial colors and flavors. Paper presented at the annual meetings of the American Medical Association, Section on Allergy, Chicago.

    Google Scholar 

  • Fish, B. (1968). Methodology in child psychopharmacology. In D. H. Efron, J. O. Cole, J. Levine, and J. R. Wittenborn (Eds.), Psychopharmacology, a review of progress, 1957–1967. Washington, DC: Public Health Service Publication No. 1836, U.S. Government Printing Office

    Google Scholar 

  • Fish, B. (1969). Problems of diagnosis and the definition of comparable groups: A neglected issue in drug research with children. American Journal of Psychiatry, 125, 900–908.

    PubMed  Google Scholar 

  • Fish, B. (1970). Psychopharmacologic response of chronic schizophrenic adults as predictors of responses in young schizophrenic children. Psychopharmacology Bulletin, 6, 12–15.

    Google Scholar 

  • Fish, B. (1971). The “one child, one drug” myth of stimulants in hyperkinesis: Importance of diagnostic categories in evaluating treatment. Archives of General Psychiatry, 25, 193–203.

    Google Scholar 

  • Fish, B., Shapiro, T., and Campbell, M. (1966). Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluoperazine. American Journal of Psychiatry, 123, 32–39.

    PubMed  Google Scholar 

  • Fisher, C., Kahn, E., Edwards, A., and Davis, D. M. (1973). A psychophysiological study of nightmare and night terrors: The suppression of stage 4 night terrors with diazepam. Archives of General Psychiatry, 28, 252–259.

    PubMed  Google Scholar 

  • Forsythe, W. I., and Redmond, A. (1970). Enuresis and the electric alarm: Study of 200 cases. British Medical Journal, 1, 211–213.

    PubMed  Google Scholar 

  • Friedhoff, A. J., and Chase, T. N. (1982). Advances in neurology: Vol. 35. Gilles de la Tourette syndrome. New York: Raven Press.

    Google Scholar 

  • Gardos, G., and Cole, J. O. (1980). Problems in assessment of tardive dyskinesia. In W. E. Fann, R. C. Smith, J. M. Davis, and E. F. Domino (Eds.), Tardive dyskinesia: Research and treatment. New York: S P Medical and Scientific Books.

    Google Scholar 

  • Gardos, G., Cole, J. O., and LaBrie, R. (1977). The assessment of tardive dyskinesia. Archives of General Psychiatry, 34, 1206–1212.

    PubMed  Google Scholar 

  • Gadow, K. D. (1985). Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacology Bulletin, 21, 291–303.

    PubMed  Google Scholar 

  • Geller, E., Ritvo, E. R., Freeman, B. J., and Yuwiler, A. (1982). Preliminary observations on the effects of fenfluramine on blood serotonin and symptoms in three autistic boys. New England Journal of Medicine, 307, 165–169.

    PubMed  Google Scholar 

  • Gittelman, R., and Koplewicz, H. (1986). Pharmacotherapy of childhood anxiety. In B. Gittelman (Ed.), Anxiety disorders of childhood. New York: Guilford Press.

    Google Scholar 

  • Gittelman, R., and Mannuzza, S (1985). Diagnosing ADD-H in adolescents. Psychopharmacology Bulletin, 21, 237–242.

    PubMed  Google Scholar 

  • Gittelman-Klein, R. (1978). Psychopharmacological treatment of anxiety disorders, mood disorders, and Tourette’s disorder in children. In M. A. Lipton, A. DiMascio, and K. F. Killam (Eds.), Psychopharmacology: A generation of progress. New York: Raven Press.

    Google Scholar 

  • Gittelman-Klein, R. (1987). Pharmacotherapy of childhood hyperactivity: An update. In H. Y. Meltzer (Ed.), Third Generation of Progress. New York: Raven Press.

    Google Scholar 

  • Gittelman-Klein, R., and Klein, D. F. (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 204–207.

    Google Scholar 

  • Gittelman-Klein, R., and Klein, D. F. ( 1973, December). The relationship between behavioral and psychological test changes in hyperkinetic children. Presented at the 12th Annual Meeting of the American College of Neuropsychopharmacology, Palm Springs, California.

    Google Scholar 

  • Gittelman-Klein, R., and Klein, D. F. (1976). Methylphenidate effects in learning disabilities: 1. Archives of General Psychiatry, 33, 655–664.

    Google Scholar 

  • Gittelman-Klein, R., Klein, D. F., Abikoff, H., Katz, S., Gloisten, A. C., and Kates, W. (1976a). Relative efficacy of methylphenidate and behavior modification in hyperkinetic children: An interim report. Journal of Abnormal Child Psychology, 4, 361–379.

    PubMed  Google Scholar 

  • Gittelman-Klein, R., Klein, D. F., Katz, S., Saraf, K. R., and Pollack, E. (1976b). Comparative effects of methylphenidate and thioridazine in hyperkinetic children: 1. Clinical results. Archives of General Psychiatry, 33, 1217–1231.

    PubMed  Google Scholar 

  • Gittelman-Klein, R., Spitzer, R., and Cantwell, D. P. (1978). Diagnostic classifications and psychopharmacological indications. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Brunner/Mazel.

    Google Scholar 

  • Glick, B. S., Schulman, D., and Turecki, S. (1971). Diazepam (Valium) treatment in childhood sleep disorders. Disease of the Nervous System, 32, 565–566.

    Google Scholar 

  • Golden, G. S. (1974). Case report-Gilles de la Tourette’s syndrome following methylphenidate administration. Developmental Medicine and Child Neurology, 16, 76.

    PubMed  Google Scholar 

  • Golden, R. R., Campbell, M., and Perry, R. (1987). A taxometric method for diagnosis of tardive dyskinesia. Journal of Psychiatric Research, 21, 233–241.

    PubMed  Google Scholar 

  • Goldstein, M., Kusano, N., Meller, E., Dancis, J., and Schwarcz, R. (1986). Dopamine agonist induced self-mutilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brain stem: Possible pharmacological model for Lesch-Nyhan syndrome. Brain Research, 367, 114–120.

    PubMed  Google Scholar 

  • Goyette, C. H., Conners, C. K., Petti, T. A., and Curtis, L. E. (1978). Effects of artificial colors in hyperkinetic children: A double-blind challenge study. Psychopharmacology Bulletin, 13, 39–40.

    Google Scholar 

  • Greenhill, L. L., Hirsch, M. L., Halpern, F., and Spalten, D. ( 1980, May). Molindone hydrochloride in the treatment of aggressive hospitalized children. Paper presented at the Annual NCDEU-NIMH Meeting, Key Biscayne, Florida.

    Google Scholar 

  • Greenhill, L. L., Barmack, J. E., Spalten, D., Anderson, M., and Halpern, F. (1981). Molindone hydrochloride in the treatment of aggressive hospitalized children. Psychopharmacology Bulletin, 17, 125.

    PubMed  Google Scholar 

  • Greenhill, L. L., Solomon, M., Pleak, R., and Ambrosini, P. ( 1987, May). Thioridazine versus molindone in conduct disorder. Paper presented at the Symposium, Neuroleptics in Children: Efficacy and Side Effects, 140th Annual Meeting of the American Psychiatric Association, Chicago.

    Google Scholar 

  • Gualtieri, C. T., Barnhill, J., McGimsey, J., and Schell, D. (1980). Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs. Journal of the American Academy of Child Psychiatry, 19, 491–510.

    PubMed  Google Scholar 

  • Gualtieri, C. T., Quade, D., Hicks, R. T., Mayo, J. P., and Schroeder, S. R. (1984). Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. American Journal of Psychiatry, 141, 20–23.

    PubMed  Google Scholar 

  • Guy, W. (1976). ECDEU assessment manual for psychopharmacology (rev.). Rockville, Md.: DHEW Publication No. (ADM) 76–338.

    Google Scholar 

  • Hanson, D. R., and Gottesman, I. I. (1976). The genetics, if any, of infantile autism and childhood schizophrenia. Journal of Autism and Childhood Schizophrenia, 6, 209–234.

    PubMed  Google Scholar 

  • Harley, J. P., Ray, R. S., Tomasi, L., Eichman, P. L., Matthews, C. G., Chun, R., Cleeland, C. S., and. Traisman, E. (1978). Hyperkinesis and food additives: Testing the Feingold hypothesis. Pediatrics, 67, 818–828.

    Google Scholar 

  • Hayes, T. A., Logan Panitch, M., and Barker, E. (1975). Imipramine dosage in children: A comment on “Imipramine and electrocardiographic abnormalities in hyperactive children.” American Journal of Psychiatry, 132, 546–547.

    PubMed  Google Scholar 

  • Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, I., Zelnik, N., Appelgate, K., Boeckx, R. L. (1986a). Effects of naltrexone in autism: Correlation with plasma opioid concentrations. Scientific Proceedings for the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 2, 11–12.

    Google Scholar 

  • Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, I., Zelnik, N., and Boeckx, R. L. (1986b). A biochemical role for opioid peptides in self-injurious behavior. Scientific Proceedings for the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 2, 29.

    Google Scholar 

  • Hersen, M., and Barlow, D. H. (1976). Single case experimental designs: Strategies for studying behavior change. New York: Pergamon Press.

    Google Scholar 

  • Herzog, J. M. ( 1978, October.) Sleep disturbance and father hunger in 18–28-month-old boys. Paper presented at the 25th Annual Meeting of the American Academy of Child Psychiatry, San Diego.

    Google Scholar 

  • Huessy, H. R., and Wright, A. L. (1970). The use of imipramine in children’s behavior disorders. Acta Paedopsychiatrica, 37, 194–199.

    PubMed  Google Scholar 

  • Hunt, R. D., Cohen, D. J., Anderson, G., and Clark, L. (1984). Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: Growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity. Life Sciences, 35, 885–897.

    PubMed  Google Scholar 

  • Irwin, S. (1968). A rational framework for the development, evaluation, and use of psychoactive drugs. American Journal of Psychiatry, 124, 1–19 (Supplement).

    PubMed  Google Scholar 

  • Kazdin, A. E. (1976). Statistical analyses for single-case experimental designs. In M. Hersen and D. H. Barlow, Single-case experimental designs: Strategies for studying behavior change. New York: Pergamon Press.

    Google Scholar 

  • Kazdin, A. E. (1981). Assessment techniques for childhood depression. A critical appraisal. Journal of the American Academy of Child Psychiatry, 20, 358–375.

    PubMed  Google Scholar 

  • Klein, D. F., Gittelman, R., Quitkin, F., and Rifkin, A. (1980a). Diagnosis and drug treatment of childhood disorders. In D. F. Klein, R. Gittelman, F. Quitkin, and A. Rifkin (Eds.), A diagnosis and drug treatment of psychiatric disorders: Adults and children ( 2nd ed. ). Baltimore: Williams and Wilkins.

    Google Scholar 

  • Klein, D. F., Gittelman, R., Quitkin, F., and Rifkin, A. (1980b). Side effects of antipsychotic drugs and their treatment. In D. F. Klein, R. Gittelman, F. Quitkin, and A. Rifkin (Eds.), A diagnosis and drug treatment of psychiatric disorders: Adults and children ( 2nd ed. ). Baltimore: Williams and Wilkins.

    Google Scholar 

  • Knights, R. M., and Viets, C. A. (1975). Effects of pemoline on hyperactive boys. Pharmacology, Biochemistry and Behavior, 3, 1107–1114.

    Google Scholar 

  • Kovacs, M., Feinberg, T. L., Crouse-Novak, M., Paulauskas, S. L., Pollock, M., and Finkelstein, R. (1984). Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression. Archives of General Psychiatry, 41, 643–649.

    PubMed  Google Scholar 

  • Kruesi, M. J. P., and Rapoport, J. L. (1986). Diet and human behavior: How much do they affect each other? Annual Review on Nutrition, 6, 113–130.

    Google Scholar 

  • Laska, E., Meisner, M., and Kushner, H. B. (1983). Optimal crossover designs in the presence of carryover effects. Biometrics, 39, 1087–1091.

    PubMed  Google Scholar 

  • Leckman, J. F., Cohen, D. J., Detlor, J., Young, J. G., Harcherick, D., and Shaywitz, B. A. (1982). Clonidine in the treatment of Tourette syndrome: A review of data. In A. J. Friedhoff and T. N. Chase (Eds.), Advances in neurology, Gilles de la Tourette Syndrome (Vol. 35 ). New York: Raven Press.

    Google Scholar 

  • Lena, B. (1979). Lithium in child and adolescent psychiatry. Archives of General Psychiatry, 36, 854–855.

    PubMed  Google Scholar 

  • Lipman, R. S., DiMascio, A., Reatig, N., and Kirson, T. (1978). Psychotropic drugs and mentally retarded children. In M. A. Lipton, A. DiMascio, and K. F. Killam (Eds.), Psycho-pharmacology: A generation of progress. New York: Raven Press.

    Google Scholar 

  • Lowe, T. L., Cohen, D. J., Detlor, J., Kremenitzer, M. W., and Shaywitz, B. A. (1982). Stimulant medications precipitate Tourette’s syndrome. Journal of the American Medical Association, 247, 1729–1731.

    PubMed  Google Scholar 

  • Lucas, A., and Weiss, M. (1971). Methylphenidate hallucinosis. Journal of the American Medical Association, 217, 1079–1081.

    PubMed  Google Scholar 

  • Mann, R. A. (1976). Assessment of behavioral excesses in children. In M. Hersen and A. S. Bellack (Eds.), Behavioral assessment: A practical handbook. Oxford: Pergamon Press.

    Google Scholar 

  • Margolin, D. I. (1978). The hyperkinetic child syndrome and brain monoamines. Journal of Clinical Psychiatry, 39, 120–123.

    PubMed  Google Scholar 

  • Mattes, J., and Gittelman, R. (1983). Growth of hyperactive children on maintenance methylphenidate. Archives of General Psychiatry, 40, 317–321.

    PubMed  Google Scholar 

  • McAndrew, J. B., Case, Q., and Treffert, D. A. (1972). Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. Journal of Autism and Childhood Schizophrenia, 2, 75–91.

    PubMed  Google Scholar 

  • McNutt, B. A., Boileau, R. A., Cohen, M. N., Sprague, R. L., and von Neumann, A. ( 1976, May). The effects of long-term stimulant medication on the growth and body composition of hyperactive children. 2. Report on 2 years. Paper presented at the Annual Early Clinical Drug Evaluation Unit Meeting, Psychopharmacology Research Branch, National Institute of Mental Health, Key Biscayne, Florida.

    Google Scholar 

  • Meinert, C. L. (1986). Clinical trials: Design, conduct and analysis. New York: Oxford University Press.

    Google Scholar 

  • Meiselas, K. D., Spencer, E. K., Oberfield, R. A., Peselow, E. D., Angrist, B., and Campbell, M. (1988). Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children. Manuscript submitted for publication.

    Google Scholar 

  • Mikkelsen, E. J., Rapoport, J. L., Nee, L., Gruenau, C., Mendelson, W., and Gillin, J. C. (1980). Childhood enuresis. I. Sleep patterns and psychopathology. Archives of General Psychiatry, 37, 1139–1144.

    PubMed  Google Scholar 

  • Muller, P. G., Crow, R. E., and Cheney, C. D. (1979). Schedule-induced locomotor activity in humans. Journal of the Experimental Analysis of Behavior, 31, 83–90.

    PubMed  Google Scholar 

  • Naruse, H., Nagahata, M., Nakane, Y., Shirahashi, K., Takesada, M., and Yamazaki, K. (1982). A multicenter double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design. Acta Paedopsychiatrica, 48, 173–184.

    PubMed  Google Scholar 

  • National Center for Health Statistics (1976). Monthly Vital Statistics Report, Vol. 25, No. 3, Supplement (HRA).

    Google Scholar 

  • Ney, P. G. (1967). Psychosis in a child, associated with amphetamine administration. Canadian Medical Association Journal, 97, 1026.

    PubMed  Google Scholar 

  • Orvaschel, H. (1985). Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacology Bulletin, 21, 737–745.

    PubMed  Google Scholar 

  • Overton, D. A. (1971). State-dependent or “dissociated” learning produced with pentobarbital. In J. A. Harvey (Ed.), Behavioral analysis of drug action: Research and commentary. Glenview, IL: Scott, Foresman.

    Google Scholar 

  • Page, J. G., Bernstein, J. E., Janicki, R. S., and Michelli, F. A. (1974a). A multi-clinic trial of pemoline in childhood hyperkinesis. In C. K. Conners (Ed.), Clinical uses of stimulant drugs in children. Amsterdam: Excerpta Medica.

    Google Scholar 

  • Page, J. G., Janicki, R. S., Bernstein, J. E., Curran, C. F., and Michelli, F. A. (1974b). Pemoline (Cylert) in the treatment of childhood hyperkinesis. Journal of Learning Disorders, 7, 498–503.

    Google Scholar 

  • Panksepp, J. (1979). A neurochemical theory of autism. (TINS) Trends in Neuroscience, 2, 174–177.

    Google Scholar 

  • Panksepp, J., and Sahley, T. L. (1987). Possible brain opioid involvement in disrupted social intent and language development in autism. In E. Schopler and G. B. Mesibov (Eds.), Neurobiological issues in autism. New York: Plenum Press.

    Google Scholar 

  • Paulson, G. W., Rizvi, C. A., and Crane, G. E. (1975). Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines. Clinical Pediatrics, 14, 953–955.

    PubMed  Google Scholar 

  • Perry, R., Campbell, M., Adams, P., Lynch, N., Spencer, E. K., Curren, E. L., and Overall, J. E. (1988). Long-term efficacy of haloperidol in autistic children: Continuous vs. Discontinuous Drug Administration. Journal of the American Academy of Child and Adolescent Psychiatry.

    Google Scholar 

  • Perry, R., Campbell, M., Adams, P., Lynch, N., Spencer, E. K., Curren, E. L., and Overall, J. E. (1988). Long-term efficacy of haloperidol in autistic children.

    Google Scholar 

  • Pessikoff, R. B., and Davis, P. C. (1971). Treatment of pavor nocturnus and somnambulism in children. American Journal of Psychiatry, 128, 778–781.

    Google Scholar 

  • Petti, T. A., and Campbell, M. (1975). Imipramine and seizures. American Journal of Psychiatry, 132, 538–540.

    PubMed  Google Scholar 

  • Platt, J. E., Campbell, M., Green, W. H., and Grega, D. M. (1984). Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Archives of General Psychiatry, 41, 657–662.

    PubMed  Google Scholar 

  • Pliszka, S. R. (1987). Review article, Tricyclic antidepressants in the treatment of children with attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 127–132.

    PubMed  Google Scholar 

  • Pliszka, S. R., Rogeness, G. A., and Medrano, M. A. (1987). Plasma dopamine-B-hydroxylase, MHPG and platelet MAO in children with depressive, anxiety and conduct disorders: Relationship to diagnosis and symptom ratings. Psychiatry Research, 24, 36–44.

    Google Scholar 

  • Polakoff, S. A., Sorgi, P. J., and Ratey, J. J. (1986). The treatment of impulsive and aggressive behavior with nadolol. Journal of Clinical Psychopharmacology, 6, 125–126.

    PubMed  Google Scholar 

  • Polizos, P., Engelhardt, D. M., Hoffman, S. P., and Waizer, J. (1973). Neurological consequences of psychotropic drug withdrawal in schizophrenic children. Journal of Autism and Childhood Schizophrenia, 3, 247–253.

    PubMed  Google Scholar 

  • Pool, D., Bloom, W., Mielke, D. H., Roniger, J. J., and Gallant, D. M. (1976). A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. Current Therapeutic Research, 19, 99–104.

    PubMed  Google Scholar 

  • Poussaint, A. F., and Ditman, K. S. (1965). A controlled study of imipramine (tofranil) in the treatment of childhood enuresis. The Journal of Pediatrics, 67, 283–290.

    Google Scholar 

  • Psychopharmacology Bulletin (1985a). Special Feature: ADD-H and mental retardation, Vol. 21.

    Google Scholar 

  • Psychopharmacology Bulletin (1985b). Special Feature: Rating scales and assessment instruments for use in pediatric psycho-pharmacology research, Vol. 21, p. 765.

    Google Scholar 

  • Psychopharmacology Bulletin (1986). Special Feature: Treatment research with the mentally retarded, mentally ill, Vol. 22.

    Google Scholar 

  • Puig-Antich, J., Blau, S., Marx, N., Greenhill, L. L., and Chambers, W. (1978). Prepubertal major depressive disorder: A pilot study. Journal of the American Academy of Child Psychiatry, 17, 695–707.

    PubMed  Google Scholar 

  • Puig-Antich, J., Perel, J., Lupatkin, W., Chambers, W. J., Tabrizi, M. A., and Stiller, R. (1979). Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: A preliminary report. Journal of the American Academy of Child Psychiatry, 18, 616–627.

    PubMed  Google Scholar 

  • Puig-Antich, J., Perel, J. M., Lupatkin, W. M., Chambers, W. J., Tabrizi, M. A., King, J., Goetz, R., Davies, M., and Stiller, R. L. (1987). Imipramine in prepubertal major depressive disorders. Archives of General Psychiatry, 44, 81–89.

    PubMed  Google Scholar 

  • Rapoport, J. L. (1985). DSM-III-R and pediatric psychophar- macology. Psychopharmacology Bulletin, 21, 803–806.

    PubMed  Google Scholar 

  • Rapoport, J. L., and Kruesi, M. J. P. ( 1984, November-December). Behavior and nutrition: A mini review. Journal of Dentistry for Children

    Google Scholar 

  • Rapoport, J. L., and Mikkelsen, E. J. (1978). Antidepressants. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Brunner/ Maze!.

    Google Scholar 

  • Rapoport, J., Abramson, A., Alexander, D., and Lott, I. (1971). Playroom observations of hyperactive children on medication. Journal of the American Academy of Child Psychiatry, 10, 524–534.

    PubMed  Google Scholar 

  • Rapoport, J. L., Quinn, P., Bradbard, G., Riddle, D., and Brooks, E. (1974). Imipramine and methylphenidate treatments of hyperactive boys. Archives of General Psychiatry, 30, 789–793.

    PubMed  Google Scholar 

  • Rapoport, J. L., Buchsbaum, M. S., Weingartner, H., Zahn, T. P., Ludlow, C., and Mikkelsen, E. J. (1980a). Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry, 37, 933–943.

    PubMed  Google Scholar 

  • Rapoport, J. L., Mikkelsen, E. J., Zavadil, A., Nee, L., Gruenau, C., Mendelson, W., and Gillin, J. C. (1980b). Childhood enuresis: 2. Psychopathology, tricyclic concentration in plasma and antienuretic effect. Archives of General Psychiatry, 37, 1146–1152.

    PubMed  Google Scholar 

  • Ratey, J. J., Mikkelsen, E. J., Smith, G. B., Upadhyaya, A., Zuckerman, S., Martell, D., Sorgi, P., Polakoff, S., and Bemporad, J. (1986). B blockers in the severely and profoundly mentally retarded. Journal of Clinical Psychopharmacology, 6, 103–107.

    PubMed  Google Scholar 

  • Ratey, J. J., Mikkelsen, E., Sorgi, P., Zuckerman, S., Polakoff, S., Bemporad, J., Bick, P., and Kadish, W. (1987). Autism: The treatment of aggressive behaviors. Journal of Clinical Psychopharmacology, 7, 35–41.

    PubMed  Google Scholar 

  • Realmuto, G.M., Erickson, W. D., Yellin, A. M., Hopwood, J. H., and Greenberg, L. M. (1984). Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. American Journal of Psychiatry, 141, 440–442.

    PubMed  Google Scholar 

  • Reeves, J. C., Werry, J. S., Elkind, G. S. and Zametkin, A. (1987). Attention Deficit, Conduct, Oppositional, and Anxiety Disorders in Children: II. Clinical Characteristics. Journal of the American Academy of Child and Adolescent Psychiatry, 26 (2), 144–155.

    PubMed  Google Scholar 

  • Reimherr, F. W., Wood, D. R., and Wender, P. H. (1980). An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction. American Journal of Psychiatry, 137, 73–75.

    PubMed  Google Scholar 

  • Ritvo, E. R. (1976). Autism: From adjective to noun. In E. R. Ritvo (Ed.), Autism: Diagnosis, current research and management. New York: Spectrum.

    Google Scholar 

  • Ritvo, E. R., Freeman, B. J., Geller, E., andYuwiler, A. (1983). Effects of fenfluramine on 14 outpatients with the syndrome of autism. Journal of the American Academy of Child Psychiatry, 22, 549–558.

    PubMed  Google Scholar 

  • Ritvo, E. R., Freeman, B. J., Yuwiler, A., Geller, E., Schroth, P., Yokota, A., Mason-Brothers, A., August, G. J., Klykylo, W., Leventhal, B., Lewis, K., Piggott, L., Realmuto, G., Stubbs, E. G., and Umansky, R. (1986). Fenfluramine treatment of autism: UCLA collaborative study of 81 patients at nine medical centers. Psychopharmacology Bulletin, 22, 133–140.

    PubMed  Google Scholar 

  • Roche, A. F., Lipman, R. S., Overall, J. E., and Hung, W. (1979). The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics, 63, 847–850.

    Google Scholar 

  • Ryan, N. D., Puig-Antich, J., Cooper, T., Rabinovich, H., Ambrosini, P., Davies, M., King, J., Tones, D., and Fried, J. (1986). Imipramine in adolescent major depression: Plasma level and clinical response. Acta Psychiatrica Scandinavica, 73, 275.

    PubMed  Google Scholar 

  • Safer, D. J., and Allen, R. P. (1973). Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics, 51, 660.

    PubMed  Google Scholar 

  • Saraf, K. R., Klein, D. F., Gittelman-Klein, R., Gootman, N., and Greenhill, P. (1978). EKG effects of imipramine treatment in children. Journal of the American Academy of Child Psychiatry, 17, 60–69.

    PubMed  Google Scholar 

  • Satterfield, J. H., Cantwell, D. P., Lesser, L. I., and Podosin, R. L. (1972). Physiological studies of the hyperkinetic child. American Journal of Psychiatry, 128, 1418–1424.

    PubMed  Google Scholar 

  • Satterfield, J. H., Cantwell, D., Saul, R. E., Lesser, L. I., and Podosin, R. L. (1973). Response to stimulant drug treatment in hyperactive children: Prediction from EEG and neurological findings. Journal of Autism and Childhood Schizophrenia, 3, 36–48.

    PubMed  Google Scholar 

  • Satterfield, J. H., Cantwell, D., and Satterfield, B. T. (1974). Pathophysiology of the hyperactive child syndrome. Archives of General Psychiatry, 31, 839–844.

    PubMed  Google Scholar 

  • Satterfield, J. H., Cantwell, D. P., Schell, A., and Blaschke, T. (1979). Growth of hyperactive children treated with methylphenidate. Archives of General Psychiatry, 36, 212–217.

    PubMed  Google Scholar 

  • Satterfield, J. H., Satterfield, B. T., and Cantwell, D. P. (1980). Multimodality treatment. A two-year evaluation of 61 hyperactive boys. Archives of General Psychiatry, 37, 915–918.

    PubMed  Google Scholar 

  • Schooler, N. R., and Kane, J. M. (1982). Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486–487.

    PubMed  Google Scholar 

  • Schulman, J. L., Stevens, T. M., and Kupst, M. J. (1977). The biomotometer: A new device for the measurement and re-mediation of hyperactivity., Child Development, 48, 1152–1154.

    Google Scholar 

  • Schulterbrandt, J. G., and Raskin, A. (Eds.). (1977). Depression in childhood: Diagnosis, treatment, and conceptual models. New York: Raven Press.

    Google Scholar 

  • Shaffer, D. (1977). Enuresis. In M. Rutter and L. Hersov (Eds.), Child psychiatry, modern approaches. London: Blackwell Scientific.

    Google Scholar 

  • Shapiro, A. K., and Shapiro, E. (1981). Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Comprehensive Psychiatry, 22, 265–273.

    PubMed  Google Scholar 

  • Shapiro, A. K., and Shapiro, E. (1982). Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of Tourette syndrome. In A. J. Friedhoff and T. N. Chase (Eds.), Gilles de la Tourette syndrome. New York: Raven Press.

    Google Scholar 

  • Shapiro, A. K., and Shapiro, E. (1984). Controlled study of pimozide vs. placebo in Tourette’s syndrome. Journal of the American Academy of Child Psychiatry, 23, 161–173.

    PubMed  Google Scholar 

  • Shapiro, A. K., Shapiro, E., and Wayne, H. (1973). Treatment of Tourette’s syndrome. Archives of General Psychiatry, 28, 92.

    PubMed  Google Scholar 

  • Shapiro, A. K., Shapiro, E. S., Brunn, R. D., and Sweet, R. C. (1978). Gilles de la Tourette Syndrome. New York: Raven Press.

    Google Scholar 

  • Shapiro, A. K., Shapiro, E., and Eisenkraft, C. J. (1983). Treatment of Gilles de la Tourette syndrome with pimozide. American Journal of Psychiatry, 140, 1183–1186.

    PubMed  Google Scholar 

  • Shaywitz, B. A., Cohen, D. J., and Bowers, M. B. (1977). CSF monoamine metabolites in children with minimal brain dysfunction. Journal of Pediatrics, 90, 67–71.

    PubMed  Google Scholar 

  • Shetty, T., and Chase, T. N. (1976). Central monoamines and hyperkinesis of childhood. Neurology, 26, 1000–1002

    PubMed  Google Scholar 

  • Sidman, M. (1960). Tactics of scientific research. New York: Basic Books.

    Google Scholar 

  • Simpson, G. M., Lee, J. H., Zoubok, B., and Gardos, G. (1979). A rating scale for tardive dyskinesia. Psychopharmacology (Berlin), 64, 171–179.

    Google Scholar 

  • Sleator, E. K., von Neumann, A., and Sprague, R. L. (1974). Hyperactive children, a continuous long-term placebo-controlled follow-up. Journal of the American Medical Association, 229, 316–317.

    PubMed  Google Scholar 

  • Snodgrass, J. G. (1975). Psychophysics. In B. Scharf and G. S. Reynolds (Eds.), Experimental sensory psychology. Glenview, IL: Scott, Foresman.

    Google Scholar 

  • Sokol, M. S. and Campbell, M. (1988). Novel psychoactive agents in the treatment of developmental disorders. In M. G. Aman and N. N. Singh (Eds.), Psychopharmacology of the developmental disabilities (pp. 146–167 ). New York: Springer-Verlag.

    Google Scholar 

  • Sokol, M. S., Campbell, M., Goldstein, M., and Kriechman, A. M. (1987). Attention deficit disorder with hyperactivity and the dopamine hypothesis: Case presentations with theoretical background. Journal of the American Academy of Child and Adolescent Psychiatry, 126, 428–433.

    Google Scholar 

  • Sprague, R. L., and Baxley, G. B. (1978). Drugs used for the management of behavior in mental retardation. In J. Wortis (Ed.), Mental retardation (Vol. 10 ). New York: Grune and Stratton.

    Google Scholar 

  • Sprague, R. L., andSleator, E. K. (1975). What is the proper dose of stimulant drugs in children? In R. Gittelman-Klein (Ed.), Recent advances in child psychopharmacology. International Journal of Mental Health, 4, 75.

    Google Scholar 

  • Sprague, R. L., and Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274–1276.

    PubMed  Google Scholar 

  • Sprague, R. L., and Werry, J. S. (1971). Methodology of psychopharmacological studies with the retarded. In N. R. Ellis (Ed.), International review of research in mental retardation. New York: Academic Press.

    Google Scholar 

  • Sprague, R. L., Barnes, K. R., and Werry, J. S. (1970). Methylphenidate and thioridazine: Learning, reaction time, activity, and classroom behavior in disturbed children. American Journal of Orthopsychiatry, 40, 615–628.

    PubMed  Google Scholar 

  • Spriet, A., and Simon, P. (1985). Methodology of clinical drug trials. New York: Karger.

    Google Scholar 

  • Stores, G. (1978). Antiepileptics (anticonvulsants). In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Brunner/ Mazel.

    Google Scholar 

  • Swanson, J. M., and Kinsbourne, M. (1980). Food dyes impair performance of hyperactive children on a laboratory learning test. Science, 207, 1485–1487.

    PubMed  Google Scholar 

  • Tardive dyskinesia: Summary of a task force report of the American Psychiatric Association. (1980). American Journal of Psychiatry, 137, 1163–1172.

    Google Scholar 

  • Tennes, K., Kreye, M., Avitable, N., and Neller, R. (1986). Behavioral correlates of excreted catecholamines and cortisol in second grade children. Journal of the American Academy of Child Psychiatry, 25, 764–770.

    PubMed  Google Scholar 

  • Turner, D. A., Purchatzke, G., Gift, T., Farmer, C., and Uhlenhuth, E. H. (1974). Intensive design in evaluating anxiolytic agents. In J. Levine, B. C. Shiele, and W. J. R. Taylor (Eds.), Principles and techniques of human research and therapeutics (Vol. 8 ). Mt. Kisco, NY: Futura.

    Google Scholar 

  • Varley, C. K. (1984). Diet and behavior of children with attention deficit disorder. Journal of the American Academy of Child Psychiatry, 23, 182–185.

    PubMed  Google Scholar 

  • Villeneuve, A. (1972). The rabbit syndrome. A peculiar extrapyramidal reaction. Canadian Psychiatric Association Journal, 17, 69–72.

    Google Scholar 

  • Waizer, J., Hoffman, S. P., Polizos, P., and Engelhardt, D. M. (1974). Outpatient treatment of hyperactive school children with imipramine. American Journal of Psychiatry, 131, 587–591.

    PubMed  Google Scholar 

  • Weinberg, W. A., Rutman, J., Sullivan, L., Penick, E. C., and Dietz, S. G. (1973). Depression in children referred to an educational diagnostic center: Diagnosis and treatment-Preliminary report. Journal of Pediatrics, 83, 1065–1072.

    PubMed  Google Scholar 

  • Weiss, B. (1982). Food additives and environmental chemicals as sources of behavior disorders. Journal of the American Academy of Child Psychiatry, 21, 144–152.

    PubMed  Google Scholar 

  • Weiss, B., Williams, J. H., Margen, S., Abrams, B., Caan, B., Citron, L. J., Cox, C., McKibben, J., Ogar, D., and Schultz, S. (1980). Behavioral responses to artificial food colors. Science, 207, 1487–1489.

    PubMed  Google Scholar 

  • Weiss, G., and Hechtman, L. (1979). The hyperactive child syndrome. Science, 205, 1348–1354.

    PubMed  Google Scholar 

  • Weiss, G., Kruger, E., Danielson, V., and Elman, M. (1975). Effect of long-term treatment of hyperactive children with methylphenidate. Canadian Medical Association Journal, 112, 159–165.

    PubMed  Google Scholar 

  • Weiss, G., Hechtman, L., Perlman, T., Hopkins, J., and Wener, A. (1979). Hyperactives as young adults: A controlled prospective ten-year follow-up of 75 children. Archives of General Psychiatry, 36, 675–681.

    PubMed  Google Scholar 

  • Wender, P. H. (1971). Minimal brain dysfunction in children. New York: Wiley-Interscience.

    Google Scholar 

  • Wender, P. H., Wood, D. R., and Reimherr, F. W. (1985). Pharmacological treatment of attention deficit disorder, residual type (ADD, RT, “Minimal Brain Dysfunction,” “Hyperactivity”) in adults. Psychopharmacology Bulletin, 21, 222–227.

    PubMed  Google Scholar 

  • Werry, J. S. (1978). Measures in pediatric psychopharmacology. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Brunner/Mazel.

    Google Scholar 

  • Werry, J. S., and Aman, M. G. (1975). Methylphenidate and haioperidol in children: Effects on attention, memory and activity. Archives of General Psychiatry, 32, 790–795.

    PubMed  Google Scholar 

  • Werry, J. S., Weiss, G., Douglas, V., and Martin, J. (1966). Studies on the hyperactive child: 3. The effect of chlorpromazine upon behavior and learning ability. Journal of the American Academy of Child Psychiatry, 5, 292–312.

    PubMed  Google Scholar 

  • Werry, J. S., Sprague, R., and Cohen, M. (1975). Conners’ Teacher Rating Scale for use in drug studies with children. Journal of Abnormal Child Psychology, 3, 217–229.

    PubMed  Google Scholar 

  • Werry, J. S., Aman, M. G., and Lampen, E. (1976). Haloperidol and methylphenidate in hyperactive children. Acta Paedopsychiatrica (Basel), 42, 26–40.

    Google Scholar 

  • Werry, J. S., Aman, M. G., and Diamond, E. (1980). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27–35.

    PubMed  Google Scholar 

  • Williams, D. T., Mehl, R., Yudofsky, S., Adams, D., and Roseman, B. (1982). The effects of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Journal of the American Academy of Child Psychiatry, 21, 129–135.

    PubMed  Google Scholar 

  • Winsberg, B. G., and Yepes, L. E. (1978). Antipsychotics. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Brunner/Mazel.

    Google Scholar 

  • Winsberg, B. G., Bialer, I., Kupietz, S., and Tobias, J. (1972). Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children. American Journal of Psychiatry, 128, 1425–1431.

    PubMed  Google Scholar 

  • Winsberg, B. G., Goldstein, S., Yepes, L. E., and Perel, J. M. (1975). Imipramine and electrocardiographic abnormalities in hyperactive children. American Journal of Psychiatry, 132, 542–545.

    PubMed  Google Scholar 

  • Woodrow, K. M. (1974). Gilles de la Tourette’s diseases: A review. American Journal of Psychiatry, 131, 1000.

    PubMed  Google Scholar 

  • World Health Organization. (1977). Manual of the international statistical classification of diseases, injuries, and causes of death (Vol. 1 ). Geneva: Author.

    Google Scholar 

  • Young, C. G., and Turner, R. K. (1965). CNS stimulant drugs and conditioning treatment of nocturnal enuresis. Behaviour Research and Therapy, 3, 93–101.

    PubMed  Google Scholar 

  • Youngerman, J., and Canino, I. (1978). Lithium carbonate use in children and adolescents. Archives of General Psychiatry, 35, 216–224.

    PubMed  Google Scholar 

  • Zametkin, A. J., Karoum, F., Linnoila, M., Rapoport, J. L., Brown, G. L., Chuang, L. W., and Wyatt, R. J. (1985). Stimulants, urinary catecholamines and indoleamines in hyperactivity: A comparison of methylphenidate and dextroamphetamine. Archives of General Psychiatry, 42, 251–255.

    PubMed  Google Scholar 

  • Ziring, P., and Teitelbaum, L. ( 1980, September). Affiliation with a university department of psychiatry: Impact on the use of psychoactive medication in a large public residential facility for mentally retarded persons. Paper presented at the Conference on the Use of Medications in Controlling the Behavior of the Mentally Retarded. University of Minnesota, Minneapolis.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Psychopharmacology Unit and Department of Psychiatry, New York University Medical Center, New York, New York, 10016, USA

    Magda Campbell & Richard Perry

  2. Autism Project, Department of Psychology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, 10314, USA

    Ira L. Cohen

  3. Children’s Psychopharmacology Unit, New York University Medical Center, New York, New York, 10016, USA

    Arthur M. Small

Authors
  1. Magda Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ira L. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arthur M. Small
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA

    Thomas H. Ollendick

  2. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Michel Hersen

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer Science+Business Media New York

About this chapter

Cite this chapter

Campbell, M., Perry, R., Cohen, I.L., Small, A.M. (1989). Psychopharmacological Treatment. In: Ollendick, T.H., Hersen, M. (eds) Handbook of Child Psychopathology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1162-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1162-2_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1164-6

  • Online ISBN: 978-1-4757-1162-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation